Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05235737 |
|---|---|
| Brief Title: | The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab (PIRG) |
| First Submitted : | February 1, 2022 |
| First Submitted that Met QC Criteria : | February 1, 2022 |
| First Posted : | February 11, 2022 |
| Last Update Submitted that Met QC Criteria : | February 22, 2022 |
| Last Update Posted : | March 10, 2022 |